Perspective of the risk and molecular mechanisms of hepatocellular carcinoma after HCV eradication in the post-DAA era: Correspondence to editorial on “Unmet needs in the post-direct-acting antivirals era: The risk and molecular mechanisms of hepatocellular carcinoma after hepatitis C virus eradication”

Chung Feng Huang; Manar Hijaze Awad; Meital Gal-Tanamy; Ming Lung Yu

doi:10.3350/CMH.2024.0472

Perspective of the risk and molecular mechanisms of hepatocellular carcinoma after HCV eradication in the post-DAA era: Correspondence to editorial on “Unmet needs in the post-direct-acting antivirals era: The risk and molecular mechanisms of hepatocellular carcinoma after hepatitis C virus eradication”

Chung Feng Huang, Manar Hijaze Awad, Meital Gal-Tanamy, Ming Lung Yu

Bar-Ilan University - Azrieli Faculty of Medicine

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	1023-1025
Number of pages	3
Journal	Clinical and molecular hepatology
Volume	30
Issue number	4
DOIs	https://doi.org/10.3350/CMH.2024.0472
State	Published - Oct 2024

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

DAA
HCV
SVR

All Science Journal Classification (ASJC) codes

Hepatology
Molecular Biology

Access to Document

10.3350/CMH.2024.0472

Cite this

Huang, C. F., Awad, M. H., Gal-Tanamy, M., & Yu, M. L. (2024). Perspective of the risk and molecular mechanisms of hepatocellular carcinoma after HCV eradication in the post-DAA era: Correspondence to editorial on “Unmet needs in the post-direct-acting antivirals era: The risk and molecular mechanisms of hepatocellular carcinoma after hepatitis C virus eradication”. Clinical and molecular hepatology, 30(4), 1023-1025. https://doi.org/10.3350/CMH.2024.0472

Huang, Chung Feng ; Awad, Manar Hijaze ; Gal-Tanamy, Meital et al. / Perspective of the risk and molecular mechanisms of hepatocellular carcinoma after HCV eradication in the post-DAA era : Correspondence to editorial on “Unmet needs in the post-direct-acting antivirals era: The risk and molecular mechanisms of hepatocellular carcinoma after hepatitis C virus eradication”. In: Clinical and molecular hepatology. 2024 ; Vol. 30, No. 4. pp. 1023-1025.

@article{79b1c3373574494e8b3d13ebaeb7df41,

title = "Perspective of the risk and molecular mechanisms of hepatocellular carcinoma after HCV eradication in the post-DAA era: Correspondence to editorial on “Unmet needs in the post-direct-acting antivirals era: The risk and molecular mechanisms of hepatocellular carcinoma after hepatitis C virus eradication”",

keywords = "DAA, HCV, SVR",

author = "Huang, {Chung Feng} and Awad, {Manar Hijaze} and Meital Gal-Tanamy and Yu, {Ming Lung}",

year = "2024",

month = oct,

doi = "10.3350/CMH.2024.0472",

language = "الإنجليزيّة",

volume = "30",

pages = "1023--1025",

journal = "Clinical and molecular hepatology",

issn = "2287-2728",

publisher = "Korean Association for the Study of the Liver",

number = "4",

}

Huang, CF, Awad, MH, Gal-Tanamy, M & Yu, ML 2024, 'Perspective of the risk and molecular mechanisms of hepatocellular carcinoma after HCV eradication in the post-DAA era: Correspondence to editorial on “Unmet needs in the post-direct-acting antivirals era: The risk and molecular mechanisms of hepatocellular carcinoma after hepatitis C virus eradication”', Clinical and molecular hepatology, vol. 30, no. 4, pp. 1023-1025. https://doi.org/10.3350/CMH.2024.0472

Perspective of the risk and molecular mechanisms of hepatocellular carcinoma after HCV eradication in the post-DAA era: Correspondence to editorial on “Unmet needs in the post-direct-acting antivirals era: The risk and molecular mechanisms of hepatocellular carcinoma after hepatitis C virus eradication”. / Huang, Chung Feng; Awad, Manar Hijaze; Gal-Tanamy, Meital et al.
In: Clinical and molecular hepatology, Vol. 30, No. 4, 10.2024, p. 1023-1025.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - Perspective of the risk and molecular mechanisms of hepatocellular carcinoma after HCV eradication in the post-DAA era

T2 - Correspondence to editorial on “Unmet needs in the post-direct-acting antivirals era: The risk and molecular mechanisms of hepatocellular carcinoma after hepatitis C virus eradication”

AU - Huang, Chung Feng

AU - Awad, Manar Hijaze

AU - Gal-Tanamy, Meital

AU - Yu, Ming Lung

PY - 2024/10

Y1 - 2024/10

KW - DAA

KW - HCV

KW - SVR

UR - http://www.scopus.com/inward/record.url?scp=85208615909&partnerID=8YFLogxK

U2 - 10.3350/CMH.2024.0472

DO - 10.3350/CMH.2024.0472

M3 - رسالة

C2 - 38946463

SN - 2287-2728

VL - 30

SP - 1023

EP - 1025

JO - Clinical and molecular hepatology

JF - Clinical and molecular hepatology

IS - 4

ER -

Huang CF, Awad MH, Gal-Tanamy M, Yu ML. Perspective of the risk and molecular mechanisms of hepatocellular carcinoma after HCV eradication in the post-DAA era: Correspondence to editorial on “Unmet needs in the post-direct-acting antivirals era: The risk and molecular mechanisms of hepatocellular carcinoma after hepatitis C virus eradication”. Clinical and molecular hepatology. 2024 Oct;30(4):1023-1025. doi: 10.3350/CMH.2024.0472

UN SDGs

Keywords

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Cite this